Home
Find a Pharmacy
Health News
Medications
Conditions
RxCoupons
Pharmacy Solutions
Find a Pharmacy
Health News
Medications
Conditions
RxCoupons
Pharmacy Solutions
FDA Alerts
Synribo for Chronic Myelogenous Leukemia Approved by FDA
The US Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease.
REFINE
medications
(-)
Remove Synribo filter
Synribo
conditions
(-)
Remove Hematology filter
Hematology
(-)
Remove Blood Cancer filter
Blood Cancer
(-)
Remove Leukemia filter
Leukemia
Cancer (1)
Apply Cancer filter